Assignee
XEQUEL BIO INC
US·3 granted patents·3 pending applications·2 citations·filing 2020–2024
Top patents by PatentIndex Score
6 records- 0190US11524049B2Formulations and methods of use for alpha connexin c-terminal (ACT) peptidesXEQUEL BIO INC·Filed 2020·Granted Dec 13, 2022·2 cites·5 claims
- 0281US12128086B2Formulations and methods of use for alpha connexin c-terminal (ACT) peptidesXEQUEL BIO INC·Filed 2022·Granted Oct 29, 2024·0 cites·5 claims
- 0366US2024408172A1Peptide formulations and ophthalmic uses thereofXEQUEL BIO INC·Filed 2024·Application pending·0 cites
- 0462US12138293B2Peptide formulations and ophthalmic uses thereofXEQUEL BIO INC·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
- 0548US2025057917A1Composition and methods for treating radiation induced injuryXEQUEL BIO INC·Filed 2024·Application pending·0 cites
- 0644US2025281574A1Compositions and methods for treating complications of viral infections and other respiratory disordersXEQUEL BIO INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XEQUEL BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →